Long-Awaited CLIA Waiver Guidance To Be Issued Mid-Year – FDA
This article was originally published in The Gray Sheet
Executive Summary
Outgoing Clinical Laboratory Improvement Advisory Committee Chair David Sundwall, MD, is pressing FDA to expedite publication of the agency's CLIA-waiver guidance
You may also be interested in...
Clinical Lab Association’s Sundwall Will Head Utah Health Department
The American Clinical Laboratory Association is seeking a senior medical and scientific officer to coordinate CLIA and CPT coding policy issues after the departure of David Sundwall, MD/PhD
FDA Draft Guidance Will Aim To Increase CLIA Waiver Flexibility
FDA plans to release a CLIA waiver draft guidance by year end, according to the Office of In Vitro Diagnostic Devices Evaluation & Safety
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”